Lipoprotein-associated phospholipase A2 is associated with the risk of dementia

被引：0
|
作者：
van Oijen, M
van der Meer, IM
Hofman, A
Witteman, JCM
Koudstaal, PPJ
Breteler, MMB
机构：
来源：
NEUROLOGY | 2005年 / 64卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A268 / A268
页数：1
相关论文
共 50 条
  • [41] Recent Developments with Lipoprotein-Associated Phospholipase A2 Inhibitors
    Ryan J. Chauffe
    Robert L. Wilensky
    Emile R. Mohler
    [J]. Current Atherosclerosis Reports, 2010, 12 : 43 - 47
  • [42] Lipoprotein-associated phospholipase A2 predicts cardiovascular events
    Persson, M
    Nilsson, JA
    Hedblad, B
    Nelson, JJ
    Berglund, G
    [J]. CIRCULATION, 2005, 112 (17) : U868 - U868
  • [43] Lipoprotein-associated phospholipase A2: A new therapeutic target
    Lonn, Eva
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 2010, 26 : 27A - 31A
  • [44] Examining the Role of Lipoprotein-Associated Phospholipase A2 in Atherosclerosis
    Gilpatrick, Timothy Edward
    Tomczak, Jonathan
    Bahnson, Brian J.
    [J]. FASEB JOURNAL, 2012, 26
  • [45] Lipoprotein-associated phospholipase A2 activity and risk of heart failure: the Rotterdam Study
    van Vark, Laura C.
    Kardys, Isabella
    Bleumink, Gysele S.
    Knetsch, Anneke M.
    Deckers, Jaap W.
    Hofman, Albert
    Stricker, Bruno H. Ch.
    Witteman, Jacqueline C. M.
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 (19) : 2346 - 2352
  • [46] Lipoprotein-associated phospholipase A2 and cardiovascular risk -: State of the evidence and future directions
    Iribarren, C
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (01) : 5 - 6
  • [47] Predicting the Risk of Cardiovascular DiseaseWhere Does Lipoprotein-Associated Phospholipase A2 Fit In?
    Natalie Khuseyinova
    Wolfgang Koenig
    [J]. Molecular Diagnosis & Therapy, 2007, 11 : 203 - 217
  • [48] Lipoprotein-associated phospholipase A2 as a risk factor for coronary vascular disease in the elderly?
    Caslake, M. J.
    Cooney, J.
    Murray, E.
    Bedford, D.
    Robertson, M.
    Nelson, J. J.
    Packard, C. J.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 484 - 484
  • [49] Lipoprotein-associated phospholipase A2: a cardiovascular risk predictor and a potential therapeutic target
    Ali, Muzammil
    Madjid, Mohammad
    [J]. FUTURE CARDIOLOGY, 2009, 5 (02) : 159 - 173
  • [50] Lipoprotein-Associated Phospholipase A2 Is a Risk Factor for Patients With Parkinson's Disease
    Wu, Zubo
    Wu, Suyuan
    Liang, Tao
    Wang, Lin
    [J]. FRONTIERS IN NEUROSCIENCE, 2021, 15
12345